News about "pharmacokinetics "

Adcendo Receives FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

Adcendo Receives FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

Tiffany-01 is an ongoing first-in-human Phase I multicenter, open-label, dose escalation study of ADCE-T02 as a monotherapy in patients with advanced solid tumors.

Pharmacokinetics | 27/02/2025 | By Aishwarya

Epigenic Therapeutics to Initiate Clinical Development of EPI-003

Epigenic Therapeutics to Initiate Clinical Development of EPI-003

This first-in-human study will assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EPI-003 in Nucleos(t)ide Analogue-Treated, Chronic Hepatitis B Patients.

Pharmacokinetics | 20/11/2024 | By Aishwarya


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members